glucose, (beta-d)-isomer and edotecarin
glucose, (beta-d)-isomer has been researched along with edotecarin in 5 studies
Research
Studies (5)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Arakawa, H; Egashira, S; Fukasawa, K; Hara, Y; Matsumoto, M; Morishima, H; Nakai, K; Nishimura, S; Ohkubo, M; Yoshinari, T | 1 |
Arakawa, H; Kodera, T; Morishima, H; Morita, M; Nishimura, S; Ohkubo, M; Okura, A | 1 |
Arakawa, H; Honma, T; Kawamoto, H; Morishima, H; Nakano, M; Nishimura, S; Nishimura, T; Ohkubo, M; Suda, H; Yoshinari, T | 1 |
Arakawa, H; Hara, Y; Komatani, H; Kotani, H; Matsumoto, M; Nakagawa, R; Nishimura, S | 1 |
Bigner, DD; Cavazos, CM; Friedman, HS; Keir, ST; Yoshinari, T | 1 |
Other Studies
5 other study(ies) available for glucose, (beta-d)-isomer and edotecarin
Article | Year |
---|---|
Mode of action of a new indolocarbazole anticancer agent, J-107088, targeting topoisomerase I.
Topics: Animals; Antineoplastic Agents; Carbazoles; Cell Line; DNA; Enzyme Inhibitors; Glucosides; Humans; Indoles; Mice; Sodium Chloride; Topoisomerase I Inhibitors | 1999 |
In vivo anti-tumor activity of a novel indolocarbazole compound, J-107088, on murine and human tumors transplanted into mice.
Topics: Animals; Antineoplastic Agents; Body Weight; Breast Neoplasms; Carbazoles; Cisplatin; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Female; Glucosides; Humans; Indoles; Leukemia P388; Lung Neoplasms; Male; Mice; Mice, Inbred Strains; Mice, Nude; Neoplasms; Paclitaxel; Prostatic Neoplasms; Time Factors | 1999 |
Synthesis and biological activities of NB-506 analogues modified at the glucose group.
Topics: Antineoplastic Agents; Carbazoles; Enzyme Inhibitors; Glucose; Glucosides; Humans; Indoles; Magnetic Resonance Spectroscopy; Mass Spectrometry; Stereoisomerism; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 2000 |
Identification of breast cancer resistant protein/mitoxantrone resistance/placenta-specific, ATP-binding cassette transporter as a transporter of NB-506 and J-107088, topoisomerase I inhibitors with an indolocarbazole structure.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Carbazoles; Colonic Neoplasms; DNA, Complementary; DNA, Neoplasm; Drug Resistance, Multiple; Enzyme Inhibitors; Fibroblasts; Gene Expression Profiling; Glucosides; Humans; Indoles; Lung Neoplasms; Mice; Neoplasm Proteins; Oligonucleotide Array Sequence Analysis; RNA, Messenger; Topoisomerase I Inhibitors; Transfection; Tumor Cells, Cultured | 2001 |
Therapeutic activity of the topoisomerase I inhibitor J-107088 [6-N-(1-hydroxymethyla-2-hydroxyl) ethylamino-12,13-dihydro-13-(beta-D-glucopyranosyl) -5H-indolo[2,3-a]-pyrrolo[3,4-c]-carbazole-5,7(6H)-dione]] against pediatric and adult central nervous sy
Topics: Adult; Animals; Antineoplastic Agents; Brain Neoplasms; Carbazoles; Child; Enzyme Inhibitors; Female; Glioma; Glucosides; Humans; Indoles; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Mice; Mice, Nude; Neoplasm Transplantation; Survival Rate; Topoisomerase I Inhibitors; Transplantation, Heterologous; Treatment Outcome; Tumor Cells, Cultured | 2001 |